Report of the Ninth Meeting of the European Technical Advisory Group on Tuberculosis Control; Copenhagen, Denmark, 25–26 November 2014
View StatisticsShow Statistical Information
AbstractThe Ninth Meeting of the European Technical Advisory Group on Tuberculosis Control was held in Copenhagen on 25–26 November 2014. The objectives of the meeting were to: (i) review the epidemiology of TB and drug-resistant TB in the WHO European Region, including the burdens and trends; (ii) review progress in implementing the recommendations of the Eighth Meeting of the European Technical Advisory Group; (iii) review progress in implementing The Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-Resistant Tuberculosis in the WHO European Region 2011–2015; and (iv) review the draft of, and make technical inputs into, the Tuberculosis Action Plan for the WHO European Region, 2016–2020.
Unknown author (2015). Report of the Ninth Meeting of the European Technical Advisory Group on Tuberculosis Control; Copenhagen, Denmark, 25–26 November 2014. WHO Regional Office for Europe. http://www.who.int/iris/handle/10665/162056
MetadataShow full item record
Showing items related by title and MeSH subject.
Tuberculose à bacilles multirésistants et tuberculose à bacilles ultrarésistants dans la Région africaine : analyse de situation, enjeux et perspectives : rapport du Directeur régional Comité régional de l’Afrique, 60 (AFR/RC60/10, 2011-10-13)
Procurement and supply management report for the WHO European Region, high MDR-TB priority countries, 2013 Unknown author (2015)Drug-resistant TB poses a threat to population health in many countries throughout the WHO European Region. in order to decrease TB rates and to prevent the development and spread of resistant TB strains, capacities to diagnose and treat patients need to be increased, and the uninterrupted supply with adequate, high-quality, efficacious and safe TB medicines needs to be ensured. In order to provide comprehensive information on policies and procedures for procurement and supply management of antiTB medicines in high-priority countries, the ...